Attitudes and prescribing patterns of extended-cycle oral contraceptives

Contraception

Volumn 84, Issue 1, 2011, Pages 71-75

  Seval, Divya L ^a   Buckley, Terry ^a   Kuehl, Thomas J ^a,b   Sulak, Patricia J ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Extended oral contraceptive regimens; Healthcare professionals; Prescribing patterns

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; GYNECOLOGY; HEALTH PERSONNEL ATTITUDE; HUMAN; MEDICAL SPECIALIST; OBSTETRICIAN; PRESCRIPTION; WITHDRAWAL BLEEDING;

ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MALE; MENSTRUATION; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES;

EID: 79958765596     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.11.015     Document Type: Article

References (13)

1. Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ. Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception 2006;74:100-3. (Pubitemid 44062466)
2. Kuehl TJ, Speikermann MA, Willis SA, Coffee A, Sulak PJ. Pituitary-ovarian hormone levels and symptoms in oral contraceptive users: comparison of a 21/7-day and extended regimen. J Reprod Med 2008;53:266-70. (Pubitemid 351644541)
3. Sullivan H, Furniss H, Spona J, Elstein M. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil Steril 1999;72:115-20. (Pubitemid 29300271)
4. Schlaff W, Lynch AM, Hughes HD, Cedars MI, Smith DL. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol 2004;190:943-51. (Pubitemid 38561509)
5. Spona J, Elstein M, Feichtinger W, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996;54:71-7. (Pubitemid 26256707)
6. Killick SR, Fitzgerald C, Davis A. Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormonefree interval. Am J Obstet Gynecol 1998;179:S18-24.
7. Sulak PJ, Willis SA, Kuehl TJ, Coffee A, Clark J. Headache and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache 2007;47:27-37. (Pubitemid 46096054)
8. Coffee A, Kuehl TK, Willis SA, Sulak PJ. Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen. Am J Obstet Gynecol 2006;195:1311-9. (Pubitemid 44635376)
9. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95:261-6. (Pubitemid 30045651)
10. Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 2007;75:444-9. (Pubitemid 46764300)
11. Sulak PJ, Buckley T, Kuehl TJ. Attitudes and prescribing preferences of health care professionals in the United States regarding the use of extended-cycle oral contraceptives. Contraception 2006;73:41-5. (Pubitemid 41811187)
12. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003;68:89-96. (Pubitemid 37101032)
13. Sulak PJ, Kuehl TJ, Coffee A, Willis S. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol 2006;195:935-41. (Pubitemid 44415645)